Back to results
US 2024/0316167 A1Published application
Treatment of urticaria
AssigneeEvax AG
InventorAntonia GABRIEL
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions, immunogenic or vaccine compositions and pharmaceutical compositions for the prevention or treatment of urticaria of equine mammals, preferably of horses. Furthermore, the invention provides methods for preventing or treating urticaria of equine mammals, preferably of horses.
Claims20
A method of prevention or treatment of urticaria of an equine mammal, wherein said method comprises administering an effective amount of a composition to said equine mammal, wherein said composition comprises:
- (a) a core particle with at least one first attachment site;
- and
- (b) at least one antigen with at least one second attachment site, wherein said at least one antigen is an equine Interleukin-5 antigen (eIL-5 antigen), wherein said eIL-5 antigen comprises a protein with the amino sequence selected from SEQ ID NO:1 or a protein with an amino acid sequence of at least 90% amino acid sequence identity with SEQ ID NO:1;
- wherein (a) and (b) are linked through said at least one first and said at least one second attachment site via at least one non-peptide covalent bond.
1 more element
Dependencies are inferred from the claim text.